BioCardia, Inc. (BCDA) Return on equity 2016–2025
BioCardia, Inc. (BCDA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-919.3%FY2025 · since FY2016: -50.1% → -919.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -919.3% | +30.0 pp |
| FY2024 | -949.3% | — |
| FY2022 | -243.4% | -121.7 pp |
| FY2021 | -121.7% | -43.4 pp |
| FY2020 | -78.2% | +542.4 pp |
| FY2019 | -620.6% | -251.8 pp |
| FY2018 | -368.9% | -258.2 pp |
| FY2017 | -110.6% | -60.5 pp |
| FY2016 | -50.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More BCDA financial trends
BCDA RevenueBCDA Net incomeBCDA Net marginBCDA Gross profitBCDA Gross marginBCDA Operating incomeBCDA Operating marginBCDA Operating cash flowBCDA Free cash flowBCDA Capital expendituresBCDA Stock buybacksBCDA Dividends paidBCDA Total assetsBCDA Total liabilitiesBCDA Shareholders’ equityBCDA overview →